These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24895814)

  • 21. Phase I/II study of hepatic arterial infusion chemotherapy with gemcitabine in patients with unresectable intrahepatic cholangiocarcinoma (JIVROSG-0301).
    Inaba Y; Arai Y; Yamaura H; Sato Y; Najima M; Aramaki T; Sone M; Kumada T; Tanigawa N; Anai H; Yoshioka T; Ikeda M;
    Am J Clin Oncol; 2011 Feb; 34(1):58-62. PubMed ID: 20177362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Factors for Survival in Patients with Advanced Intrahepatic Cholangiocarcinoma Treated with Gemcitabine plus Cisplatin as First-Line Treatment.
    Ishimoto U; Kondo S; Ohba A; Sasaki M; Sakamoto Y; Morizane C; Ueno H; Okusaka T
    Oncology; 2018; 94(2):72-78. PubMed ID: 29017161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic arterial infusion of gemcitabine plus oxaliplatin as second-line treatment for locally advanced intrahepatic cholangiocarcinoma: preliminary experience.
    Ghiringhelli F; Lorgis V; Vincent J; Ladoire S; Guiu B
    Chemotherapy; 2013; 59(5):354-60. PubMed ID: 24821200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gemcitabine combined with 5-fluorouracil and cisplatin (GFP) in patients with advanced biliary tree cancers: a pilot study.
    Yamashita Y; Taketomi A; Fukuzawa K; Yoshizumi T; Uchiyama H; Simada M; Shirabe K; Wakasugi K; Maehara Y
    Anticancer Res; 2006; 26(1B):771-5. PubMed ID: 16739352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience.
    Knox JJ; Hedley D; Oza A; Siu LL; Pond GR; Moore MJ
    Ann Oncol; 2004 May; 15(5):770-4. PubMed ID: 15111345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy.
    Fiteni F; Jary M; Monnien F; Nguyen T; Beohou E; Demarchi M; Dobi E; Fein F; Cleau D; Fratté S; Nerich V; Bonnetain F; Pivot X; Borg C; Kim S
    BMC Gastroenterol; 2014 Aug; 14():143. PubMed ID: 25117717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical presentation and outcomes of patients with biliary malignancies: the Aga Khan University experience.
    Kumar S; Masood N; Shaikh AJ; Valimuhammad AT; Haider G; Lal A; Niamatullah N
    Asian Pac J Cancer Prev; 2009; 10(3):463-6. PubMed ID: 19640192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of advanced intrahepatic cholangiocarcinoma successfully treated with chemosensitivity test-guided systemic chemotherapy.
    Abe K; Wakatsuki T; Katsushima F; Monoe K; Kanno Y; Takahashi A; Yokokawa J; Ohira H
    World J Gastroenterol; 2009 Nov; 15(41):5228-31. PubMed ID: 19891026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) chemotherapy in patients with advanced biliary tree cancers.
    Yamashita Y; Taketomi A; Itoh S; Harimoto N; Tsujita E; Sugimachi K; Gion T; Maehara Y
    Jpn J Clin Oncol; 2010 Jan; 40(1):24-8. PubMed ID: 19770132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment outcome of palliative chemotherapy in inoperable cholangiocarcinoma in Thailand.
    Butthongkomvong K; Sirachainan E; Jhankumpha S; Kumdang S; Sukhontharot OU
    Asian Pac J Cancer Prev; 2013; 14(6):3565-8. PubMed ID: 23886146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: seven cases.
    Uka K; Aikata H; Takaki S; Kawaoka T; Saneto H; Miki D; Takahashi S; Toyota N; Ito K; Chayama K
    World J Gastroenterol; 2008 Apr; 14(16):2602-8. PubMed ID: 18442216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of HAI-FUDR and Systemic Gemcitabine and Cisplatin in Unresectable Cholangiocarcinoma: A Dose Finding Single Center Study.
    Pietge H; Sánchez-Velázquez P; Akhoundova D; Siebenhüner A; Winder T; Bachmann H; Nguyen-Kim TDL; Breitenstein S; Knuth A; Petrowsky H; Pestalozzi B; Clavien PA; Samaras P
    Oncology; 2021; 99(5):300-309. PubMed ID: 33657549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic arterial infusion chemotherapy in combination with pegylated interferon-α-2b for advanced hepatocellular carcinoma.
    Okita K; Yamasaki T; Hamabe S; Saeki I; Harima Y; Terai S; Sakaida I
    Hepatogastroenterology; 2012; 59(114):533-7. PubMed ID: 22353519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin.
    Martin RCG; Simo KA; Hansen P; Rocha F; Philips P; McMasters KM; Tatum CM; Kelly LR; Driscoll M; Sharma VR; Crocenzi TS; Scoggins CR
    Ann Surg Oncol; 2022 Sep; 29(9):5462-5473. PubMed ID: 35657463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.
    Gusani NJ; Balaa FK; Steel JL; Geller DA; Marsh JW; Zajko AB; Carr BI; Gamblin TC
    J Gastrointest Surg; 2008 Jan; 12(1):129-37. PubMed ID: 17851723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC).
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Hepatogastroenterology; 2008; 55(85):1380-4. PubMed ID: 18795694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
    Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
    Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma.
    Franssen S; Holster JJ; Jolissaint JS; Nooijen LE; Cercek A; D'Angelica MI; Homs MYV; Wei AC; Balachandran VP; Drebin JA; Harding JJ; Kemeny NE; Kingham TP; Klümpen HJ; Mostert B; Swijnenburg RJ; Soares KC; Jarnagin WR; Groot Koerkamp B
    Ann Surg Oncol; 2024 Jan; 31(1):115-124. PubMed ID: 37814188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Adjuvant Gemcitabine Combined with Low-dose 5-Fluorouracil and Cisplatin Chemotherapy for Advanced Biliary Carcinoma.
    Morine Y; Shimada M; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Yamada S; Imura S
    Anticancer Res; 2017 Nov; 37(11):6421-6428. PubMed ID: 29061828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [GEM plus CDDP Combination Therapy for Unresectable Biliary Tract Cancer-A Single Institution Experience].
    Muneta M; Ohmura Y; Takeda Y; Katsura Y; Shinke G; Kinoshita M; Aoyama S; Kihara Y; Katsuyama S; Ikeshima R; Hiraki M; Sugimura K; Masuzawa T; Hata T; Murata K
    Gan To Kagaku Ryoho; 2023 Feb; 50(2):239-241. PubMed ID: 36807184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.